inflammatory bowel disease ibd comprising of ulcerative colitis uc and crohns disease cd is a major ailment affecting the small and large bowelin clinics ibd is treated using 5amninosalicylates antibiotics the steroids and immunomodulatorsunfortunately the long term usages of these agents are associated with undue side effects and compromise the therapeutic advantageaccordingly there is a need for novel agents that are effective acceptable and non toxic to humanspreclinical studies in experimental animals have shown that curcumin an active principle of the indian spice turmeric curcuma longa linn is effective in preventing or ameliorating uc and inflammationover the last few decades there has been increasing interest in the possible role of curcumin in ibd and several studies with various experimental models of ibd have shown it to be effective in mediating the inhibitory effects by scavenging free radicals increasing antioxidants influencing multiple signaling pathways especially the kinases mapk erk inhibiting myeloperoxidase cox1 cox2 lox tnfα ifnγ inos inhibiting the transcription factor nfκbclinical studies have also shown that coadministration of curcumin with conventional drugs was effective to be welltolerated and treated as a safe medication for maintaining remission to prevent relapse and improve clinical activity indexlarge randomized controlled clinical investigations are required to fully understand the potential of oral curcumin for treating ibd